November 1, 2019 / 6:46 PM / 18 days ago

Trump nominates MD Anderson oncologist as U.S. FDA Commissioner

Nov 1 (Reuters) - U.S. President Donald Trump has nominated Dr. Stephen Hahn, chief medical executive of the University of Texas MD Anderson Cancer Center, to lead the Food and Drug Administration, the White House said on Friday.

Hahn, a radiation oncologist who has been at MD Anderson in Houston since 2015, if confirmed would follow Scott Gottlieb as FDA commissioner. Hahn’s nomination passes over Ned Sharpless, a previous director of the National Cancer Institute, who is currently serving s acting FDA commissioner.

Reporting by Deena Beasley Editing by Bill Berkrot

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below